₹240.75*
MRP ₹267.5
10% off
₹227.37*
MRP ₹267.5
15% CB
₹40.13 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition :
CLINDAMYCIN-250MG
Manufacturer/Marketer :
Zee Laboratories Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
ClindamycinIndinavir
Severe
ClindamycinAtazanavir
Severe
Drug-Drug Interactions
Login/Sign Up
ClindamycinIndinavir
Severe
How does the drug interact with Klariva 250 mg Tablet:
Concomitant use of Klariva 250 mg Tablet with indinavir may increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with indinavir if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhoea.
Concomitant use of Klariva 250 mg Tablet with indinavir may increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with indinavir if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhoea.
ClindamycinAtazanavir
Severe
How does the drug interact with Klariva 250 mg Tablet:
Co-administration of Klariva 250 mg Tablet with Atazanavir may increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with atazanavir if prescribed by the doctor. Consult the prescriber if you experience persistent nausea, vomiting, diarrhea, or abdominal pain. Do not discontinue the medication without consulting a doctor.
Co-administration of Klariva 250 mg Tablet with Atazanavir may increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with atazanavir if prescribed by the doctor. Consult the prescriber if you experience persistent nausea, vomiting, diarrhea, or abdominal pain. Do not discontinue the medication without consulting a doctor.
ClindamycinEstradiol
Severe
How does the drug interact with Klariva 250 mg Tablet:
When taken in combination, Klariva 250 mg Tablet can lower the amount or action of estradiol.
How to manage the interaction:
Co-administration of Estradiol with Klariva 250 mg Tablet can result in an interaction, but it can be taken if a doctor has advised it. Do not stop using any medications without a doctor's advice.
When taken in combination, Klariva 250 mg Tablet can lower the amount or action of estradiol.
How to manage the interaction:
Co-administration of Estradiol with Klariva 250 mg Tablet can result in an interaction, but it can be taken if a doctor has advised it. Do not stop using any medications without a doctor's advice.
ClindamycinItraconazole
Severe
How does the drug interact with Klariva 250 mg Tablet:
Concomitant use of Klariva 250 mg Tablet with itraconazole can reduce the metabolism and increase the levels of Klariva 250 mg Tablet in the body. This may increase the risk or severity of side effects.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with itraconazole if prescribed by the doctor. Consult a doctor immediately if you experience persistent vomiting, nausea, abdominal pain, or diarrhea. Do not stop using any medications without first talking to your doctor.
Concomitant use of Klariva 250 mg Tablet with itraconazole can reduce the metabolism and increase the levels of Klariva 250 mg Tablet in the body. This may increase the risk or severity of side effects.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with itraconazole if prescribed by the doctor. Consult a doctor immediately if you experience persistent vomiting, nausea, abdominal pain, or diarrhea. Do not stop using any medications without first talking to your doctor.
ClindamycinKetoconazole
Severe
How does the drug interact with Klariva 250 mg Tablet:
Coadministration of use of Klariva 250 mg Tablet with ketoconazole can increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with ketoconazole if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain or diarrhea. Do not discontinue any medication without consulting a doctor. Do not discontinue any medication without consulting a doctor.
Coadministration of use of Klariva 250 mg Tablet with ketoconazole can increase the effects of Klariva 250 mg Tablet.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with ketoconazole if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain or diarrhea. Do not discontinue any medication without consulting a doctor. Do not discontinue any medication without consulting a doctor.
ClindamycinBotulinum toxin
Severe
How does the drug interact with Klariva 250 mg Tablet:
Taking Klariva 250 mg Tablet with Botulinum toxin can increase the risk or severity of side effects.
How to manage the interaction:
Taking Klariva 250 mg Tablet with Botulinum toxin together can result in an interaction, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Klariva 250 mg Tablet with Botulinum toxin can increase the risk or severity of side effects.
How to manage the interaction:
Taking Klariva 250 mg Tablet with Botulinum toxin together can result in an interaction, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
ClindamycinAtracurium
Severe
How does the drug interact with Klariva 250 mg Tablet:
Co-administration of Klariva 250 mg Tablet with Atracurium can increase the risk of muscle weakness.
How to manage the interaction:
Taking Klariva 250 mg Tablet with Atracurium together can possibly result in an interaction, but it can be taken if a doctor has advised it. "Klariva 250 mg Tablet can affect the muscles and nerves in your body. When used with other medications that also affect the muscles and nerves, it can cause a serious problem called neuromuscular blockade. If you have trouble breathing or can't breathe at all, please call your doctor right away." Do not stop using any medications without a doctor's advice.
Co-administration of Klariva 250 mg Tablet with Atracurium can increase the risk of muscle weakness.
How to manage the interaction:
Taking Klariva 250 mg Tablet with Atracurium together can possibly result in an interaction, but it can be taken if a doctor has advised it. "Klariva 250 mg Tablet can affect the muscles and nerves in your body. When used with other medications that also affect the muscles and nerves, it can cause a serious problem called neuromuscular blockade. If you have trouble breathing or can't breathe at all, please call your doctor right away." Do not stop using any medications without a doctor's advice.
ClindamycinCholera, live attenuated
Severe
How does the drug interact with Klariva 250 mg Tablet:
Co-administration of Klariva 250 mg Tablet may reduce the activity of the cholera vaccine.
How to manage the interaction:
Talk to your doctor before receiving the Cholera vaccine if you are currently being treated with Klariva 250 mg Tablet or have been treated within the last 14 days. To ensure adequate vaccine response, you should not receive cholera vaccine until at least 14 days after you complete antibiotic therapy. Do not discontinue the medication without consulting a doctor.
Co-administration of Klariva 250 mg Tablet may reduce the activity of the cholera vaccine.
How to manage the interaction:
Talk to your doctor before receiving the Cholera vaccine if you are currently being treated with Klariva 250 mg Tablet or have been treated within the last 14 days. To ensure adequate vaccine response, you should not receive cholera vaccine until at least 14 days after you complete antibiotic therapy. Do not discontinue the medication without consulting a doctor.
ClindamycinFosphenytoin
Severe
How does the drug interact with Klariva 250 mg Tablet:
When Klariva 250 mg Tablet is taken with Fosphenytoin, it can cause the body to process Klariva 250 mg Tablet faster.
How to manage the interaction:
Although there is a possible interaction between Klariva 250 mg Tablet and Fosphenytoin, you can take these medicines together if prescribed by your doctor. If you notice any symptoms like sudden drowsiness, fatigue, confusion, itching, burning, or tingling sensation, abnormal body movements, or loss of coordination, make sure to contact your doctor right away. Do not stop using any medications without first talking to your doctor.
When Klariva 250 mg Tablet is taken with Fosphenytoin, it can cause the body to process Klariva 250 mg Tablet faster.
How to manage the interaction:
Although there is a possible interaction between Klariva 250 mg Tablet and Fosphenytoin, you can take these medicines together if prescribed by your doctor. If you notice any symptoms like sudden drowsiness, fatigue, confusion, itching, burning, or tingling sensation, abnormal body movements, or loss of coordination, make sure to contact your doctor right away. Do not stop using any medications without first talking to your doctor.
ClindamycinBacitracin
Severe
How does the drug interact with Klariva 250 mg Tablet:
Co-administration of Klariva 250 mg Tablet with Bacitracin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. If you develop diarrhoea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may harm the kidney.
Co-administration of Klariva 250 mg Tablet with Bacitracin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Klariva 250 mg Tablet can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. If you develop diarrhoea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may harm the kidney.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Author Details
Drug-Diseases Interactions
CLINDAMYCIN-250MGOther bacterial intestinal infections
Severe
CLINDAMYCIN-250MGDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-250MGOther bacterial intestinal infections
Severe
How does the disease interact with Klariva 250 mg Tablet:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-250MGDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Klariva 250 mg Tablet:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-250MGOther diseases of liver
Moderate
How does the disease interact with Klariva 250 mg Tablet:
The liver is the primary site of Klariva 250 mg Tablet metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Klariva 250 mg Tablet and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Klariva 250 mg Tablet therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Klariva 250 mg Tablet is primarily metabolized by the liver. Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Klariva 250 mg Tablet metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Klariva 250 mg Tablet and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Klariva 250 mg Tablet therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Klariva 250 mg Tablet is primarily metabolized by the liver. Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-250MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Klariva 250 mg Tablet:
Klariva 250 mg Tablet is partially removed by the kidney. Klariva 250 mg Tablet should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Klariva 250 mg Tablet concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with severely impaired renal function. Serum Klariva 250 mg Tablet concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Klariva 250 mg Tablet is partially removed by the kidney. Klariva 250 mg Tablet should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Klariva 250 mg Tablet concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with severely impaired renal function. Serum Klariva 250 mg Tablet concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-250MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Klariva 250 mg Tablet:
Klariva 250 mg Tablet is partially removed by the kidney. Klariva 250 mg Tablet should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Klariva 250 mg Tablet concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with severely impaired renal function. Serum Klariva 250 mg Tablet concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Klariva 250 mg Tablet is partially removed by the kidney. Klariva 250 mg Tablet should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Klariva 250 mg Tablet concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Klariva 250 mg Tablet should be administered cautiously in patients with severely impaired renal function. Serum Klariva 250 mg Tablet concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
